GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.

The market for digital dose inhalers for asthma and COPD will be worth $3.56 billion in 2024, according to a new prediction from Grand View Research. Though connected inhalers are a new market, ...

Propeller Health, the leading digital health solution for respiratory medicine, announced a partnership with Aptar Pharma (Aptar), a global drug delivery systems provider, including technology for ...

With sensors and digital resources from Propeller Health, clinicians at UC Davis Health can closely monitor daily activities of patients with COPD and asthma for early intervention, according to a ...

MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...

NEW YORK, July 31, 2024 /PRNewswire/ -- The global smart inhaler technology market size is estimated to grow by USD 46.37 million from 2023-2027, according to Technavio. The market is estimated to ...

Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians ...